New association schedules with Oxaliplatin, Topotecan and 5-FU in sensitive and 5-FU-resistant cell lines.

被引：0
|
作者：
Taron, M
Plasencia, C
Abad, A
Guillot, M
Martin, C
Font, A
Barnadas, A
Rosell, R
机构：
[1] Hosp Germans Trias & Pujol, Med Oncol Serv, Badalona 08916, Barcelona, Spain
[2] Hosp Germans Trias & Pujol, Mol Biol Lab, Badalona 08916, Barcelona, Spain
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S13 / S13
页数：1
相关论文
共 50 条
  • [31] 5-FU related symptomatic cardiotoxicity in colorectal cancer patients: The impact of the new schedules
    Bencardino, K.
    Manzoni, M.
    Delfanti, S.
    Chatzileontiadou, S.
    Danova, M.
    ANNALS OF ONCOLOGY, 2007, 18 : VII70 - VII71
  • [32] Cellular determinants for the interactions of 5-fluorouracil (5-FU) and irinotecan (CPT-11) in human colon carcinoma cell lines.
    Mans, DRA
    Grivicich, I
    Peters, GJ
    Neumann, JM
    Sporleder, H
    Schwartsmann, G
    CLINICAL CANCER RESEARCH, 1999, 5 : 3839S - 3839S
  • [33] Bolus 5-fluorouracil (5-FU) In Combination With Oxaliplatin Is Safe and Well Tolerated in Patients Who Experienced Coronary Vasospasm With Infusional 5-FU or Capecitabine
    Chakrabarti, Sakti
    Sara, Jaskanwal
    Lobo, Ronstan
    Eiring, Rachel
    Finnes, Heidi
    Mitchell, Jessica
    Hartgers, Mindy
    Okano, Akiko
    Halfdanarson, Thorvardur
    Grothey, Axel
    CLINICAL COLORECTAL CANCER, 2019, 18 (01) : 52 - 57
  • [34] CAPECITABINE VERSUS 5-FU IN ASSOCIATION WITH OXALIPLATIN OR CPT11: TOXICITY AND PATIENT COMPLIANCE
    Spalletta, B.
    Tomao, S.
    Manna, A.
    Santini, D.
    Longo, F.
    Coletta, D.
    Petricola, F.
    Proietti, E.
    Borgomastro, A.
    Di Seri, M.
    ANNALS OF ONCOLOGY, 2004, 15 : 69 - 69
  • [35] Overexpression of MicroRNA-122 Re-sensitizes 5-FU-Resistant Colon Cancer Cells to 5-FU Through the Inhibition of PKM2 In Vitro and In Vivo
    He, Jinxia
    Xie, Ganfeng
    Tong, Jingtao
    Peng, Yonghai
    Huang, Haihui
    Li, Jianjun
    Wang, Ning
    Liang, Houjie
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2014, 70 (02) : 1343 - 1350
  • [36] Overexpression of MicroRNA-122 Re-sensitizes 5-FU-Resistant Colon Cancer Cells to 5-FU Through the Inhibition of PKM2 In Vitro and In Vivo
    Jinxia He
    Ganfeng Xie
    Jingtao Tong
    Yonghai Peng
    Haihui Huang
    Jianjun Li
    Ning Wang
    Houjie Liang
    Cell Biochemistry and Biophysics, 2014, 70 : 1343 - 1350
  • [37] TIMP-2 as a predictive biomarker in 5-Fu-resistant colorectal cancer
    Yaoqing Li
    Chuchu Xu
    Renjun Zhu
    Liyijing Shen
    Gengyuan Hu
    Kelong Tao
    Feng Tao
    Zengxin Lu
    Guolin Zhang
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 7235 - 7246
  • [38] RADIOTHERAPY 5-FU ASSOCIATION IN ADVANCED CANCER OF PANCREAS
    BOLLA, M
    PECCOUD, A
    FOURNET, J
    RACHAIL, M
    CHAMPETIER, JM
    VROUSOS, C
    BULLETIN DU CANCER, 1984, 71 (04) : 391 - 392
  • [39] Identification of 5-FU inducible genes in tumour cell lines by cDNA mircroarray
    Maxwell, PJ
    Longley, DB
    Boyer, J
    Latif, T
    Allen, W
    Lynch, M
    Harkin, DP
    Johnston, PG
    BRITISH JOURNAL OF CANCER, 2002, 86 : S21 - S21
  • [40] Rationale for the administration of systemic 5-FU in combination with heated intraperitonal oxaliplatin
    Badrudin, D.
    Sideris, L.
    Leblond, F. A.
    Pichette, V.
    Cloutier, A. S.
    Drolet, P.
    Dube, P.
    SURGICAL ONCOLOGY-OXFORD, 2018, 27 (02): : 275 - 279
12345